Needham & Company Reiterates a 'Buy' on Itron (ITRI); Mixed 3Q Results With Some Good, Some Bad; Longer-Term Outlook Remains Healthy
Go back to Needham & Company Reiterates a 'Buy' on Itron (ITRI); Mixed 3Q Results With Some Good, Some Bad; Longer-Term Outlook Remains Healthy| Itron, Inc. (NASDAQ: ITRI) | Delayed: 101.56 -1.16 (1.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $102.72 | 52 Week High | $62.55 | |||
| Open | $102.82 | 52 Week Low | $29.02 | |||
| Day High | $102.92 | P/E | N/A | |||
| Day Low | $101.25 | EPS | $-3.74 | |||
| Volume | 441,465 | |||||
